Vesicoureteral reflux (VUR) is associated with increased risks of urinary tract infection, renal
scarring and reflux nephropathy. We review advancements over the last two decades in our …

OBJECTIVE: Published success rates of dextranomer/hyaluronic acid (Dx/HA) injection for
pediatric vesicoureteral reflux (VUR) vary widely. Our objective of this study was to assess …

Purpose: We evaluated the difference in the febrile urinary tract infection rate in small
children with dilating vesicoureteral reflux randomly allocated to 3 management alternatives …

Purpose: We compared reflux status in children with dilating vesicoureteral reflux treated in
3 groups, including low dose antibiotic prophylaxis, endoscopic therapy and a surveillance …

Vesicoureteral reflux (VUR) is the most common uropathy affecting children. Compared to
children without VUR, those with VUR have a higher rate of pyelonephritis and renal …

CONTEXT: Vesicoureteral reflux (VUR) is present in approximately 1% of children in North
America and Europe and is associated with an increased risk of pyelonephritis and renal …

OBJECTIVES: Hyaluronic acid is a protective barrier of the urothelium. A damaged
glycosaminoglycan layer may increase the possibility of bacterial adherence and infection …

BACKGROUND: Caudal blockade is a common technique for pediatric postoperative
analgesia. While safe and effective, caudal opioids are associated with troublesome side …

Primary vesicoureteral reflux (VUR) is one of the most common urological abnormalities in
infants and children. The association of VUR, urinary tract infection (UTI) and renal …

Vesicoureteral reflux (VUR) affects around 1% of all children, making it the most common
paediatric anomaly of the urinary tract. Around a third of infants and children with febrile UTI …